Novo Nordisk has claimed an edge in the increasingly ... clinical trials to be more effective than Wegovy at stimulating weight loss and, according to Lilly, is on course to be approved for ...

Shares of Novo Nordisk slipped in Monday morning trading after the company announced results of its latest weight-loss drug trial. Novo's results from its Redefine 2 late-stage trial of ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better compete with rival Eli Lilly in the populous nation, two sources familiar ...

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular ... Both treatments, as well as the company's weekly weight loss injection Wegovy, contain the active ingredient ...

India's anti-obesity drug market shows significant growth. It has increased fourfold in five years. Lifestyle diseases and ...